1. MicroRNA profiles in neuroblastoma: Differences in risk and histology groups
   Kemal Ergin et al, 2018, Asia-Pacific Journal of Clinical Oncology CrossRef
2. The challenge of defining “ultra‐high‐risk” neuroblastoma
   Daniel A. Morgenstern et al, 2019, Pediatric Blood & Cancer CrossRef
3. MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma
   Natalia Andreeva et al, 2023, Molecular Biology Reports CrossRef
4. The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
   Irene Veneziani et al, 2019, Oncotarget CrossRef
5. MicroRNA‐379 mediates pigmentation, migration and proliferation of melanocytes by targeting the insulin‐like growth factor 1 receptor
   Bo Liu et al, 2020, Experimental Dermatology CrossRef
6. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA–mRNA Network in Neuroblastoma Via Bioinformatics Analysis
   Bo Chen et al, 2021, Neurochemical Research CrossRef
7. Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
   Omidvar Rezaei et al, 2021, Frontiers in Oncology CrossRef
8. PIWI‐interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells
   Jyoti Roy et al, 2020, Journal of Cellular Physiology CrossRef
9. The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
   Danny Misiak et al, 2021, Frontiers in Oncology CrossRef
10. Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma
    Soraya Epp et al, 2023, International Journal of Molecular Sciences CrossRef
11. miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
    Srinivas Chava et al, 2020, Molecular Oncology CrossRef
12. A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a
    Valerio Piacenti et al, 2019, Bioorganic Chemistry CrossRef
13. Comparison of the human tumor metastasis gene expression level in neuroblastoma patients with MYCN amplification and 2p gain: Pilot study
    Katarzyna Szewczyk, 2018, Pediatric Hematology Oncology Journal CrossRef
14. Modulation of Expression of miRNAs for Therapeutic Effects in Human Malignant Neuroblastoma
    Swapan K. Ray, 2019, Neuroblastoma CrossRef
15. Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors
    Magdalena Zakrzewska et al, 2019, BMC Cancer CrossRef
16. MicroRNA dysregulation interplay with childhood abdominal tumors
    Karina Bezerra Salomão et al, 2019, Cancer and Metastasis Reviews CrossRef
17. SNHG16 knockdown inhibits tumorigenicity of neuroblastoma in children via miR-15b-5p/PRPS1 axis
    Yirong Ge et al, 2020, NeuroReport CrossRef
18. Emerging therapeutic targets for neuroblastoma
    Natarajan Aravindan et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
19. Neuroblastoma and the epigenome
    Irfete S. Fetahu et al, 2021, Cancer and Metastasis Reviews CrossRef
20. Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
    Alan Van Goethem et al, 2023, NAR Cancer CrossRef
21. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases
    Leslimar Rios-Colon et al, 2019, Tumor Biology CrossRef